What is AcuityMD?
AcuityMD operates at the intersection of healthcare technology and commercial intelligence. The company provides a sophisticated software platform designed to assist medical device manufacturers in navigating complex market landscapes. By integrating data across sales, marketing, medical education, and product development, AcuityMD enables organizations to track product utilization, analyze clinical outcome variations, and identify strategic opportunities for physician engagement.
The platform serves as a critical infrastructure layer for medtech firms, allowing them to optimize their market access strategies. By providing granular visibility into how and where medical devices are deployed, AcuityMD empowers its clients to make informed decisions that improve site-of-care performance and patient health outcomes. This unique value proposition has established the company as an essential partner for enterprises seeking to modernize their commercial operations in an increasingly data-centric healthcare environment.
How much funding has AcuityMD raised?
AcuityMD has raised a total of $163M across 4 funding rounds:
Other Financing Round
$7M
Series A
$31M
Series B
$45M
Series C
$80M
Other Financing Round (2021): $7M with participation from Benchmark and Ajax Health
Series A (2022): $31M led by Benchmark, Ajax Health, Artisanal Ventures, and Redpoint Venture Partners
Series B (2024): $45M supported by Atreides Management, StepStone Group, and ICONIQ Growth
Series C (2026): $80M featuring StepStone Group, Redpoint Ventures, Benchmark, ICONIQ Capital, and Atreides Management
Key Investors in AcuityMD
ICONIQ Growth
ICONIQ Growth partners with exceptional entrepreneurs and leaders who drive global impact and change, leveraging a vibrant ecosystem of founders to amplify portfolio success from early growth stage to IPO.
StepStone Group
StepStone Group is a global private markets investment firm providing customized investment solutions and advisory services to institutional clients, including pension funds and sovereign wealth funds.
Benchmark
Benchmark is a prominent San Francisco-based venture capital firm known for providing early-stage capital and strategic guidance to high-growth technology startups.
What's next for AcuityMD?
With the successful closure of its latest funding round, AcuityMD is poised to enter a phase of aggressive market expansion and product innovation. The strategic focus will likely center on deepening the platform's analytical capabilities and expanding its footprint within the global medical device industry. As the company scales, it will continue to leverage its ecosystem of high-profile investors to refine its go-to-market strategy and solidify its role as the standard-bearer for commercial intelligence in medtech.
Future growth initiatives are expected to prioritize the integration of advanced predictive modeling to further assist manufacturers in identifying underserved patient populations and optimizing medical education efforts. By maintaining its focus on high-impact, data-driven solutions, AcuityMD is well-positioned to sustain its momentum and drive long-term value for its stakeholders and the broader healthcare community.
